



Thank you for the opportunity to respond to the letter
from Dr Serrablo and colleagues commenting on our paper
(Bui et al) published in HPB 2002 volume 4; 1: 5–10. We
appreciate your interest in our paper and are pleased to
respond to your questions and comments.
1. The ultrasonic dissector (Cavitron) was used rou-
tinely from mid 1988 onwards. We agree with the observa-
tion that the 31 patients operated on between 1987–1990
(mostly Cavitron era) had less blood loss than the patients
operated on between 1980–1986 (before the Cavitron era).
Our analysis concurs with the notion that use of the Cavit-
ron contributes to less blood loss; however, the impact of a
low CVP is still a more important factor. The evidence for
this can be found in table 4 in our paper, where we compare
20 cases done just before 1991 and 20 cases just after 1991
when the Minimal Blood Loss (MBL) strategy (which
includes low CVP) was introduced. In both these groups
the Cavitron was used routinely. The only significant dif-
ference between the two groups was the median Estimated
Blood Loss (EBL). Prior to 1991 it was 4,100 ml and after
1991 it was 1,650 ml (p value , 0.01). 
2. We agree that erythropoietin (EPO) is now an
integral part of a blood conservation strategy. However,
during most of the time covered by our study EPO was
not available.
3. Intra-operative autotransfusion or the cell saver
became available to us only in the mid-1990s and hence
was used in only 21 patients. In estimating blood loss we
did count the non-saved blood as part of the EBL. The
amount of cells saved that was transfused was considered as
autologus blood. Given the small number of patients, sub-
group analysis is neither feasible nor practical.
4. ‘Other morbidity’ relates to pneumonia, wound infec-
tions and other non-specific complications. The MBL pro-
gram led to a three-fold reduction in the incidence of
sepsis. We attribute this to the five-fold reduction in the
number of homologous blood units transfused. Although
other factors may have contributed to the reduction in sep-
sis, we think the main factor is the reduction in the homol-
ogous blood transfusions.
We thank Serrablo et al. for their careful assessment of
our paper and their support for the thesis of our work, e.g.
that an integrated blood conservation programme and a
reduction of homologous blood transfusions are important
goals in liver surgery.
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